SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-003671
Filing Date
2023-03-01
Accepted
2023-03-01 16:35:29
Documents
2
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 form3-03012023_090311.html 3  
1 form3-03012023_090311.xml 3 9806
2 ex24-03012023_090311.htm EX-24 6326
  Complete submission text file 0001415889-23-003671.txt   17463
Mailing Address 28 SEVINOR RD MARBLEHEAD MA 01945
Business Address
Kowalsky Matthew Paul (Reporting) CIK: 0001705824 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39746 | Film No.: 23694197

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations